| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
ATP binding cassette subfamily A member 13 | 0.722 | 0.308 | 8.8E-114 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 1996 | 2010 | ||||||||
|
ATP binding cassette subfamily B member 4 | 0.529 | 0.615 | 2.2E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.100 | None | 0.972 | 36 | 0 | 1990 | 2017 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | |||||||||
|
ACD shelterin complex subunit and telomerase recruitment factor | 0.603 | 0.731 | 1.1E-12 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2017 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
atypical chemokine receptor 3 | 0.428 | 0.885 | 0.39 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
acid phosphatase 1 | 0.566 | 0.731 | 1.8E-08 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
acyl-CoA synthetase long chain family member 4 | 0.561 | 0.769 | 0.98 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
activin A receptor like type 1 | 0.493 | 0.769 | 9.7E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
ADAM metallopeptidase domain 12 | 0.565 | 0.731 | 5.7E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ADAM metallopeptidase domain 9 | 0.560 | 0.654 | 2.9E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
AF4/FMR2 family member 2 | 0.636 | 0.538 | 1.00 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
alpha fetoprotein | 0.429 | 0.885 | 1.1E-11 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 1993 | 2000 | ||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2019 | ||||||||
|
aldo-keto reductase family 1 member A1 | 0.510 | 0.846 | 6.7E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2015 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
group | 0.070 | None | 0.857 | 7 | 0 | 1991 | 2018 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
group | 0.100 | None | 1.000 | 11 | 2 | 1998 | 2017 | ||||||||
|
Leukemia, acute lymphocytic, susceptibility to, 1 | 0.636 | 0.269 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1994 | 2007 | |||||||||
|
alkaline phosphatase, placental | 0.487 | 0.808 | 1.8E-13 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
alpha-1-microglobulin/bikunin precursor | 0.537 | 0.731 | 2.8E-13 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 |